Abstract
The authors reviewed respiratory adverse events and deaths spontaneously reported to Xcel Pharmaceuticals associated with diazepam rectal gel. Over 2 million doses have been prescribed. The authors identified nine respiratory adverse events and three deaths. The respiratory events associated with prolonged seizures had a good outcome. The deaths occurred in the context of a prolonged seizure and respiratory depression was not the main symptom. When used as recommended, diazepam rectal gel has a low rate of serious morbidity or mortality.
Original language | English (US) |
---|---|
Pages (from-to) | 1768-1770 |
Number of pages | 3 |
Journal | Neurology |
Volume | 64 |
Issue number | 10 |
DOIs | |
State | Published - May 24 2005 |
ASJC Scopus subject areas
- Clinical Neurology